Parkinson's disease prevalence, age distribution and staging in Colombia

JL Orozco, JA Valderrama-Chaparro… - Neurology …, 2020 - pmc.ncbi.nlm.nih.gov
Parkinson's disease (PD) has the second highest prevalence among neurodege-nerative
diseases. In Colombia, PD population dynamics are currently unknown. Health records offer …

A comparison of resource use of insured and uninsured venezuelan migrants: evidence from the hospital setting

SI Prada, E Pulgarín-Rodríguez… - Journal of Immigrant and …, 2023 - Springer
Background There is no characterization of resource use in the hospital setting for
immigrants in Colombia, we aimed to describe the resource use by Venezuelan immigrants …

Prevalence and Cost of Care for Parkinson's Disease in Luxembourg: An Analysis of National Healthcare Insurance Data

S Schmitz, M Vaillant, C Renoux, RL Konsbruck… - PharmacoEconomics …, 2022 - Springer
Background Parkinson's disease (PD) is the second most common neurodegenerative
disorder, with an increasing prevalence worldwide. Estimates of the economic burden …

Saturdays‐in‐Motion: Education and Empowerment through an Interdisciplinary Team Approach for Parkinson's Disease in Cali‐Colombia

BE Muñoz, V Quintana-Peña, MC Gonzalez… - Parkinson's …, 2020 - Wiley Online Library
Introduction. Parkinson's disease (PD) is one of the most prevalent age‐related
neurodegenerative disorders. The progression of PD produces an important disease burden …

Trastornos del estado del ánimo en pacientes con Enfermedad de Parkinson atendidos en una clínica de tercer nivel de complejidad en la ciudad de Cali-Colombia …

AM Vidal, JMC Prieto, AR Meza - Revista Científica de Salud y …, 2024 - revistavitalia.org
Introducción La ansiedad es una presentación sintomática no motora de la Enfermedad de
Parkinson (EP), condición neurodegenerativa de aparición en los adultos, considerada …

[HTML][HTML] Time until modification of antiparkinsonian therapy in a group of patients from Colombia

A Valencia-Vásquez, A Gaviria-Mendoza… - Revista de …, 2023 - ncbi.nlm.nih.gov
Results. A total of 3,224 patients (51.8% men) with a mean age of 73.1±13.5 years started
treatment with antiparkinsonian agents. After five years, 2,046 patients (63.5%) had …

[HTML][HTML] Tiempo hasta la modificación de la terapia antiparkinsoniana en un grupo de pacientes de Colombia

A Valencia-Vásquez, A Gaviria-Mendoza… - Revista de …, 2023 - ncbi.nlm.nih.gov
Resultados. Un total de 3.224 pacientes (51, 8%, hombres), con edad media de 73, 1±13, 5
años, iniciaron tratamiento con fármacos antiparkinsonianos. Después de cinco años, 2.046 …

[PDF][PDF] ELIZABETH ROMERO GUTIÉRREZ

OA CARRIÓN - 2022 - ru.dgb.unam.mx
La enfermedad de Parkinson (EP), es un trastorno neurodegenerativo incurable
heterogéneo, frecuente, cuya prevalencia aumenta con la edad1. Se caracteriza por …

Urinary Incontinence among Parkinson's Disease Patients in Alberta: Incidence and Risk Predictors

SA Laboni - 2020 - era.library.ualberta.ca
Background: Parkinson's disease (PD) is one of the most common neurological chronic
diseases among older adults in Canada. More than 100,000 Canadians are diagnosed with …

[PDF][PDF] Research Article Saturdays-in-Motion: Education and Empowerment through an Interdisciplinary Team Approach for Parkinson's Disease in Cali-Colombia

BE Muñoz, V Quintana-Peña, MC Gonzalez… - 2020 - academia.edu
Introduction. Parkinson's disease (PD) is one of the most prevalent age-related
neurodegenerative disorders. e progression of PD produces an important disease burden in …